ORIC Pharmaceuticals, Inc. (ORIC)
NASDAQ: ORIC · Real-Time Price · USD
9.24
-0.24 (-2.53%)
Nov 5, 2024, 11:14 AM EST - Market open
ORIC Pharmaceuticals Employees
ORIC Pharmaceuticals had 100 employees as of December 31, 2023. The number of employees increased by 14 or 16.28% compared to the previous year.
Employees
100
Change (1Y)
14
Growth (1Y)
16.28%
Revenue / Employee
n/a
Profits / Employee
-$1,107,820
Market Cap
651.81M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 100 | 14 | 16.28% |
Dec 31, 2022 | 86 | 8 | 10.26% |
Dec 31, 2021 | 78 | 17 | 27.87% |
Dec 31, 2020 | 61 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Pacific Biosciences of California | 796 |
Cytek Biosciences | 676 |
Ironwood Pharmaceuticals | 267 |
OrthoPediatrics | 247 |
AnaptysBio | 117 |
Y-mAbs Therapeutics | 100 |
Olema Pharmaceuticals | 74 |
Mereo BioPharma Group | 33 |
ORIC News
- 19 hours ago - ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 3 days ago - ORIC® Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 26 days ago - ORIC® Pharmaceuticals Announces Presentation at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics - GlobeNewsWire
- 4 weeks ago - ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - ORIC Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operational Updates - GlobeNewsWire
- 3 months ago - ORIC Pharmaceuticals Expands Leadership Team with the Appointment of Keith Lui as Senior Vice President of Commercial and Medical Affairs - GlobeNewsWire